Sight Sciences, Inc. (SGHT)
- Previous Close
4.2000 - Open
4.2500 - Bid 4.0200 x 100
- Ask 4.1000 x 100
- Day's Range
3.9101 - 4.2500 - 52 Week Range
2.0300 - 8.4500 - Volume
213,839 - Avg. Volume
198,652 - Market Cap (intraday)
209.911M - Beta (5Y Monthly) 2.45
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9800 - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.68
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
www.sightsciences.comRecent News: SGHT
View MorePerformance Overview: SGHT
Trailing total returns as of 6/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGHT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGHT
View MoreValuation Measures
Market Cap
209.91M
Enterprise Value
141.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.63
Price/Book (mrq)
2.70
Enterprise Value/Revenue
1.81
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-63.24%
Return on Assets (ttm)
-21.77%
Return on Equity (ttm)
-52.88%
Revenue (ttm)
78.11M
Net Income Avi to Common (ttm)
-49.4M
Diluted EPS (ttm)
-0.9800
Balance Sheet and Cash Flow
Total Cash (mrq)
108.77M
Total Debt/Equity (mrq)
52.12%
Levered Free Cash Flow (ttm)
-8.84M